NEW YORK, Oct. 31 – Three executives at Celera Genomics, including the company’s chief operating officer, have left the company in the past five weeks, GenomeWeb has learned. 

Peter Chambre, former COO, has left the firm for Applera, Celera’s parent company. Heather Kowalski, a Celera spokeswoman, said he will be working with Tony White, Applera’s chairman, president, and CEO. 

A title for the former COO has not yet been determined, according to his secretary, and it was not immediately clear who will replace him at Celera.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.